Literature DB >> 31777460

Colonic Polyps: Diagnosis and Surveillance.

Michael B Huck1, Jaime L Bohl1.   

Abstract

Colorectal cancer begins as a polyp that is a benign growth on the mucosal surface of the colon or rectum. Over a period of 5 to 15 years, polyps can degenerate into a cancer, thus invading the colonic wall. Colorectal screening methods are designed to diagnose and remove polyps before they acquire invasive potential and develop into cancer. Screening for colorectal cancer can prevent and reduce mortality. Given the benefits and effectiveness of screening, guidelines exist from multiple organizations. These guidelines risk-stratify patients to determine the age of screening initiation and the interval for repeat screening. Categories of colorectal cancer risk include average risk, increased risk, and high risk based on individual and family medical history. Screening methods vary widely in the ability to diagnose and treat polyps and in the degree of invasiveness or risk of complication to the patient. Colonoscopy is held as the "gold standard" by which all other methods are compared; however, less-invasive modalities including computed tomographic colonography are increasing in popularity. © Thieme Medical Publishers.

Entities:  

Keywords:  CT colonography; colonoscopy; colorectal polyps; colorectal screening

Year:  2016        PMID: 31777460      PMCID: PMC6878826          DOI: 10.1055/s-0036-1584091

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  73 in total

Review 1.  Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.

Authors:  P D Collins; C Mpofu; A J Watson; J M Rhodes
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 2.  Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

Authors:  Paul Hewitson; Paul Glasziou; Eila Watson; Bernie Towler; Les Irwig
Journal:  Am J Gastroenterol       Date:  2008-05-13       Impact factor: 10.864

3.  One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

Authors:  D A Lieberman; D G Weiss
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

4.  Addressing Low Colorectal Cancer Screening in African Americans: Using Focus Groups to Inform the Development of Effective Interventions.

Authors:  Folasade P May; Cynthia B Whitman; Ksenia Varlyguina; Erica G Bromley; Brennan M R Spiegel
Journal:  J Cancer Educ       Date:  2016-09       Impact factor: 2.037

Review 5.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

6.  Accuracy of CT colonography for detection of large adenomas and cancers.

Authors:  C Daniel Johnson; Mei-Hsiu Chen; Alicia Y Toledano; Jay P Heiken; Abraham Dachman; Mark D Kuo; Christine O Menias; Betina Siewert; Jugesh I Cheema; Richard G Obregon; Jeff L Fidler; Peter Zimmerman; Karen M Horton; Kevin Coakley; Revathy B Iyer; Amy K Hara; Robert A Halvorsen; Giovanna Casola; Judy Yee; Benjamin A Herman; Lawrence J Burgart; Paul J Limburg
Journal:  N Engl J Med       Date:  2008-09-18       Impact factor: 91.245

7.  Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening.

Authors:  R Hüneburg; F Lammert; C Rabe; N Rahner; P Kahl; R Büttner; P Propping; T Sauerbruch; C Lamberti
Journal:  Endoscopy       Date:  2009-04-01       Impact factor: 10.093

8.  A comparison of fecal occult-blood tests for colorectal-cancer screening.

Authors:  J E Allison; I S Tekawa; L J Ransom; A L Adrain
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

9.  Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

10.  Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial.

Authors:  Steve Halligan; Kate Wooldrage; Edward Dadswell; Ines Kralj-Hans; Christian von Wagner; Rob Edwards; Guiqing Yao; Clive Kay; David Burling; Omar Faiz; Julian Teare; Richard J Lilford; Dion Morton; Jane Wardle; Wendy Atkin
Journal:  Lancet       Date:  2013-02-14       Impact factor: 79.321

View more
  2 in total

Review 1.  Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer.

Authors:  Zahra Pezeshkian; Stefania Nobili; Noshad Peyravian; Bahador Shojaee; Haniye Nazari; Hiva Soleimani; Hamid Asadzadeh-Aghdaei; Maziar Ashrafian Bonab; Ehsan Nazemalhosseini-Mojarad; Enrico Mini
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

2.  Diagnostic challenges in a CMMRD patient with a novel mutation in the PMS2 gene: a case report.

Authors:  Shiqing Tan; Xiaoting Wu; Aoxue Wang; Li Ying
Journal:  BMC Med Genomics       Date:  2021-07-12       Impact factor: 3.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.